Home › Blood Disorders › California › Baldwin Park
Blood Disorders clinical trials in Baldwin Park, CA
4 studies for Blood Disorders are looking for participants at sites in and around Baldwin Park (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Phase 1/2 Study to Evaluate the Safety and Efficacy of Dibotatug (DR-01) in Adults With Bone Marrow Failure Syndromes
RecruitingPhase 1/2
- Dren Investigational Site, Duarte · 4 mi away
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
RecruitingPhase 3
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi away
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
RecruitingPhase 2
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi away
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
RecruitingPhase 1
- City of Hope, Duarte · 4 mi away
About Blood Disorders
Blood disorders affect one or more parts of the blood and prevent your blood from doing its job. Find out about the types, causes, and treatments.
More about Blood Disorders on MedlinePlus
Blood Disorders trials in other cities
- Houston, TX11 studies
- Atlanta, GA11 studies
- Boston, MA10 studies
- Los Angeles, CA10 studies
- New York City, NY9 studies
- The Bronx, NY8 studies
- Durham, NC7 studies
- Nashville, TN7 studies
- Mountain View, CA7 studies
- San Diego, CA6 studies
- Seattle, WA6 studies
- Indianapolis, IN5 studies
Other studies in Baldwin Park
- Breast Cancer43 studies
- Acute Myeloid Leukemia41 studies
- Colorectal Cancer37 studies
- Non-Small Cell Lung Cancer36 studies
- Cancer (all types)34 studies
- Prostate Cancer31 studies
- Metastatic Cancer30 studies
- Ovarian Cancer27 studies
- Myelodysplastic Syndromes27 studies
- Lung Cancer23 studies
- Multiple Myeloma23 studies
- Lymphoma22 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.